Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Thomas Eleveld

Postdoc
Thomas Eleveld
Thomas Eleveld
--
Phone 088 97 25 614

--

  • Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma

    • sep. 2022
    • Kaylee M., Keller, et al
    • Frontiers in Oncology
  • Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

    • apr. 2022
    • Dennis M, Timmerman, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Engineering large-scale chromosomal deletions by CRISPR-Cas9

    • dec. 2021
    • Thomas F, Eleveld, et al
    • Nucleic acids research
  • The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors

    • okt. 2021
    • Dennis M, Timmerman, et al
    • International journal of molecular sciences
  • Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy

    • aug. 2021
    • Caroline C C, Hulsker, et al
    • International journal of molecular sciences
View all publications